SC 13G | 2024-03-05 | GRIFFIN ASSET MANAGEMENT, INC. | Accelerate Diagnostics, Inc | 1,219,724 | 8.4% | EDGAR |
SC 13D/A | 2023-06-20 | SCHULER JACK W | Accelerate Diagnostics, Inc | 58,012,207 | 40.6% | EDGAR |
SC 13D | 2023-06-20 | Indaba Capital Management, L.P. | Accelerate Diagnostics, Inc | 15,972,241 | 9.9% | EDGAR |
SC 13D/A | 2023-06-08 | SCHULER JACK W | Accelerate Diagnostics, Inc | 20,260,952 | 20.0% | EDGAR |
SC 13G/A | 2022-02-24 | FEINBERG LARRY N | Accelerate Diagnostics, Inc | 3,257,503 | 5.0% | EDGAR |
SC 13G/A | 2022-02-11 | FEINBERG LARRY N | Accelerate Diagnostics, Inc | 3,627,549 | 5.5% | EDGAR |
SC 13D/A | 2021-12-03 | SCHULER JACK W | Accelerate Diagnostics, Inc | 18,409,240 | 26.4% | EDGAR |
SC 13D/A | 2021-10-05 | SCHULER JACK W | Accelerate Diagnostics, Inc | 17,186,959 | 25.7% | EDGAR |
SC 13G/A | 2021-02-16 | FEINBERG LARRY N | Accelerate Diagnostics, Inc | 3,806,139 | 6.7% | EDGAR |
SC 13G/A | 2021-02-12 | CREDIT SUISSE AG/ | Accelerate Diagnostics, Inc | 1,765,390 | 3.1% | EDGAR |
SC 13G/A | 2020-02-14 | FEINBERG LARRY N | Accelerate Diagnostics, Inc | 4,696,652 | 8.6% | EDGAR |
SC 13G/A | 2020-02-13 | CREDIT SUISSE AG/ | Accelerate Diagnostics, Inc | 3,103,749 | 567.0% | EDGAR |
SC 13G | 2019-02-13 | CREDIT SUISSE AG/ | Accelerate Diagnostics, Inc | 3,938,058 | 726.0% | EDGAR |
SC 13G/A | 2019-02-06 | FEINBERG LARRY N | Accelerate Diagnostics, Inc | 4,811,522 | 8.9% | EDGAR |
SC 13D/A | 2018-04-12 | SCHULER JACK W | Accelerate Diagnostics, Inc | 17,079,791 | 30.1% | EDGAR |
SC 13D/A | 2018-02-20 | SCHULER JACK W | Accelerate Diagnostics, Inc | 16,037,868 | 29.0% | EDGAR |
SC 13G/A | 2018-02-14 | FEINBERG LARRY N | Accelerate Diagnostics, Inc | 4,892,337 | 8.8% | EDGAR |
SC 13G/A | 2017-02-06 | FEINBERG LARRY N | Accelerate Diagnostics, Inc | 5,032,389 | 9.8% | EDGAR |
SC 13D/A | 2016-02-25 | SCHULER JACK W | Accelerate Diagnostics, Inc | 14,106,565 | 27.5% | EDGAR |
SC 13D/A | 2016-02-25 | PATIENCE JOHN | Accelerate Diagnostics, Inc | 6,551,346 | 12.8% | EDGAR |